🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could result in users administering products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the service has taken down violative material and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or administering at home.

Within minutes of joining one community, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Pricing

Inside these groups, posts display black plastic packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to potentially significant medical dangers”.